Rapamycin impairs antigen uptake of human dendritic cells

Transplantation

Volumn 75, Issue 1, 2003, Pages 137-145

  Monti, Paolo ^a   Mercalli, Alessia ^a   Eugenio Leone, Biagio ^a,b   Valerio, Di Carlo ^a,c   Allavena, Paola ^d   Piemonti, Lorenzo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RAPAMYCIN;

ALLOGRAFT; ANTIGEN DETECTION; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL STIMULATION; DENDRITIC CELL; ENDOCYTOSIS; FLOW CYTOMETRY; GRAFT SURVIVAL; HUMAN; HUMAN CELL; MIXED LYMPHOCYTE CULTURE; PRIORITY JOURNAL;

ANTIGENS; CELL DIFFERENTIATION; CELL POLARITY; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; ENDOCYTOSIS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-4; PHAGOCYTOSIS; SIROLIMUS; TACROLIMUS BINDING PROTEIN 1A;

EID: 0037439786     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200301150-00025     Document Type: Article

References (36)

1. Seghal SN, Baker H, Vezina C. Rapamycin (AY-22, 989), a new antifungal antibiotic: II. Fermentation, isolation and characterization. J Antibiot 1975; 282: 727.
2. Calne RY, Collier DS, Lim S, et al. Rapamycin for immunosuppression in organ allografting. Lancet 1989; 22: 227.
3. Chen H, Wu J, Xu D, et al. Reversal of ongoing heart, kidney, and pancreas allograft rejection and suppression of accelerated heart allograft rejection in the rat by rapamycin. Transplantation 1993; 56: 661.
4. Terada N, Lucas JJ, Szepesi A, et al. Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle. Cell Physiol 1993; 154: 7.
5. Aagaard-Tillery KM, Jelinek DF. Inhibition of B lymphocyte cell cycle progression and differentiation by rapamycin. Cell Immunol 1994; 156: 493.
6. Taylor-Fishwick DA, Kahan M, Hiestand P, et al. Evidence that rapamycin has differential effect on IL-4 function. Transplantation 1993; 56: 368.
7. Kimball PM, Kerman RH, Kahan BD. Production of synergistic but not identical mechanisms of immunosuppression by rapamycin and cyclosporine. Transplantation 1991; 51: 486.
8. Seghal SN. Rapamune (RAPA, rapamycin, rapamycin): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clin Biochem 1998; 31: 335.
9. Mellman I, Steinman RM. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001; 106: 271.
10. Lanzavecchia A, Sallusto F. Regulation of T cell immunity by dendritic cells. Cell 2001; 106: 263.
11. Banchereau J, Schuler-Thurner B, Palucka AK, et al. Dendritic cells as vector for therapy. Cell 2001; 106: 271.
12. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245.
13. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9: 271.
14. Josien R, Heslan M, Brouard S, et al. Critical requirement for graft passenger leukocytes in allograft tolerance induced by donor blood transfusion. Blood 1998; 92: 4539.
15. Hackstein H, Morelli AE, Thomson AW. Designer dendritic cells for the tolerance induction: guided not misguided missiles. Trends Immunol 2001; 22: 437.
16. Uccini S, Siriani MC, Vincenti L, et al. Kaposi's sarcoma cells express the macrophage-associated antigen mannose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patients. Am J Pathol 1997; 150: 929.
17. Piemonti L, Monti P, Allavena P, et al. Glucocorticoids affect human dendritic cell differentiation and maturation. J Immunol 1999; 162: 6473.
18. Piemonti L, Monti P, Sironi M, et al. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 2000; 164: 4443.
19. Allavena P, Piemonti L, Longoni D, et al. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur J Immunol 1998; 28: 359.
20. Woltman AM, de Fijter JW, Kamerling SWA, et al. Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophages. Blood 2001; 98: 174.
21. Sallusto F, Cella M, Danieli C, et al. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995; 182: 389.
22. Harris PE, Cortesini R, Suciu-Foca N. Indirect allorecognition in solid organ transplantation. Rev Immunogenet 1999; 1: 297.
23. Calabi F, Jarvis JM, Martin L, et al. Two classes of CD1 genes. Eur J Immunol 1989; 19: 285-292.
24. Jackman RM, Moody DB, Porcelli SA. Mechanisms of lipid antigen presentation by CD1. Crit Rev Immunol 1999; 19: 49.
25. Park S-H, Bendelac A. CD1-restricted T-cell responses and microbial infection. Nature 2000; 406: 788.
26. Shinkai K, Locksley RM. CD1, tuberculosis, and the evolution of major histocompatibility complex molecules. J Exp Med 2000; 191: 907.
27. Hackstein H, Taner T, Logar AJ, et al. Rapamycin inhibits macropynocitosis and mannose receptor-mediated endocytosis by bone marrowderived dendritic cells. Blood 2002; 100: 1084.
28. + T cells. J Immunol 1995; 154: 5071.
29. Gao JX, Madrenas J, Zeng W, et al. CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection. Immunology 1999; 98: 159.
30. Vasquez EM. Rapamycin: a new agent for prevention of renal allograft rejection. Am J Health-Syst Pharm 2000; 57: 437.
31. Brattstrom C, Sawe J, Tyden G. Kinetics and dynamics of single oral doses of rapamycin in sixteen renal transplant recipients. Ther Drug Monit 1997; 19: 397.
32. Zimmerman JJ, Kahan BD. Pharmacokinetics of rapamycin in stable renal transplant patients after multiple oral dose administration. J Clin Pharmacol 1997; 37: 405.
33. West MA, Prescott AR, Eskelinen EL, et al. Rac is required for constitutive macropinocytosis by dendritic cells but does not control its downregulation. Curr Biol 2000; 10: 839.
34. de Baey A, Lanzavecchia A. The role of aquaporins in dendritic cell macropinocytosis. J Exp Med 2000; 191: 743.
35. Chou M, Blenis J. The 70 kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Racl. Cell 1996; 85: 573.
36. Miyamoto S, Safer B. Immunosuppressants FK506 and rapamycin have different effects on the biosynthesis of cytoplasmic actin during the early period of T cell activation. Biochem J 1999; 344: 803.